abstract |
The present invention relates to a tricyclic compound of general formula (I), as defined herein, which exhibits an antagonistic activity at V1 and / or V2 receptors and exhibits an antagonistic activity in vasopressin in vivo, a methods for the use of these compounds in the treatment of diseases characterized by excessive renal reabsorption of water, and processes for the preparation of those compounds. |